169 related articles for article (PubMed ID: 38542016)
41. Size of tooth crowns and position of teeth concerning the extension of facial plexiform neurofibroma in patients with neurofibromatosis type 1.
Friedrich RE; Giese M; Stelljes C; Froeder C; Scheuer HA
Anticancer Res; 2012 May; 32(5):2207-14. PubMed ID: 22593511
[TBL] [Abstract][Full Text] [Related]
42. The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin.
Rice FL; Houk G; Wymer JP; Gosline SJC; Guinney J; Wu J; Ratner N; Jankowski MP; La Rosa S; Dockum M; Storey JR; Carroll SL; Albrecht PJ; Riccardi VM
PLoS One; 2019; 14(5):e0216527. PubMed ID: 31107888
[TBL] [Abstract][Full Text] [Related]
43. Treatment of MEK inhibitor-induced paronychia with doxycycline.
Sun Q; Antaya RJ
Pediatr Dermatol; 2020 Sep; 37(5):970-971. PubMed ID: 32644232
[TBL] [Abstract][Full Text] [Related]
44. Pediatric cervical kyphosis in the MRI era (1984-2008) with long-term follow up: literature review.
Menezes AH; Traynelis VC
Childs Nerv Syst; 2022 Feb; 38(2):361-377. PubMed ID: 34806157
[TBL] [Abstract][Full Text] [Related]
45. Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Fisher MJ; Shih CS; Rhodes SD; Armstrong AE; Wolters PL; Dombi E; Zhang C; Angus SP; Johnson GL; Packer RJ; Allen JC; Ullrich NJ; Goldman S; Gutmann DH; Plotkin SR; Rosser T; Robertson KA; Widemann BC; Smith AE; Bessler WK; He Y; Park SJ; Mund JA; Jiang L; Bijangi-Vishehsaraei K; Robinson CT; Cutter GR; Korf BR; ; Blakeley JO; Clapp DW
Nat Med; 2021 Jan; 27(1):165-173. PubMed ID: 33442015
[TBL] [Abstract][Full Text] [Related]
46. Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?
Chelleri C; Scala M; De Marco P; Traverso M; Ognibene M; Bruno I; Piccolo G; Striano P; Severino M; Zara F; Diana MC; Pavanello M
Front Pediatr; 2023; 11():1051026. PubMed ID: 36923276
[TBL] [Abstract][Full Text] [Related]
47. Resection of small plexiform neurofibromas in neurofibromatosis type 1 children.
Friedrich RE; Schmelzle R; Hartmann M; Fünsterer C; Mautner VF
World J Surg Oncol; 2005 Jan; 3(1):6. PubMed ID: 15683544
[TBL] [Abstract][Full Text] [Related]
48. A Population Pharmacokinetic Assessment of the Effect of Food on Selumetinib in Patients with Neurofibromatosis Type 1-Related Plexiform Neurofibromas and Healthy Volunteers.
Zuo P; Arefayene M; Pan WJ; Freshwater T; Monteleone J
Clin Pharmacol Drug Dev; 2024 Apr; ():. PubMed ID: 38591154
[TBL] [Abstract][Full Text] [Related]
49. Trametinib for orbital plexiform neurofibromas in young children with neurofibromatosis type 1.
Toledano H; Dotan G; Friedland R; Cohen R; Yassur I; Toledano-Alhadef H; Constantini S; Rootman MS
Childs Nerv Syst; 2021 Jun; 37(6):1909-1915. PubMed ID: 33751171
[TBL] [Abstract][Full Text] [Related]
50. Using a qualitative approach to conceptualize concerns of patients with neurofibromatosis type 1 associated plexiform neurofibromas (pNF) across the lifespan.
Lai JS; Jensen SE; Patel ZS; Listernick R; Charrow J
Am J Med Genet A; 2017 Jan; 173(1):79-87. PubMed ID: 27666129
[TBL] [Abstract][Full Text] [Related]
51. Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas.
Carrió M; Mazuelas H; Richaud-Patin Y; Gel B; Terribas E; Rosas I; Jimenez-Delgado S; Biayna J; Vendredy L; Blanco I; Castellanos E; Lázaro C; Raya Á; Serra E
Stem Cell Reports; 2019 Feb; 12(2):411-426. PubMed ID: 30713041
[TBL] [Abstract][Full Text] [Related]
52. Neurofibromatosis 1 (von Recklinghausen Disease).
Yoshida Y
Keio J Med; 2023 Aug; ():. PubMed ID: 37635082
[TBL] [Abstract][Full Text] [Related]
53. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study.
Weiss B; Widemann BC; Wolters P; Dombi E; Vinks A; Cantor A; Perentesis J; Schorry E; Ullrich N; Gutmann DH; Tonsgard J; Viskochil D; Korf B; Packer RJ; Fisher MJ
Neuro Oncol; 2015 Apr; 17(4):596-603. PubMed ID: 25314964
[TBL] [Abstract][Full Text] [Related]
54. Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.
Robertson KA; Nalepa G; Yang FC; Bowers DC; Ho CY; Hutchins GD; Croop JM; Vik TA; Denne SC; Parada LF; Hingtgen CM; Walsh LE; Yu M; Pradhan KR; Edwards-Brown MK; Cohen MD; Fletcher JW; Travers JB; Staser KW; Lee MW; Sherman MR; Davis CJ; Miller LC; Ingram DA; Clapp DW
Lancet Oncol; 2012 Dec; 13(12):1218-24. PubMed ID: 23099009
[TBL] [Abstract][Full Text] [Related]
55. Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib.
Campagne O; Yeo KK; Fangusaro J; Stewart CF
Clin Pharmacokinet; 2021 Mar; 60(3):283-303. PubMed ID: 33354735
[TBL] [Abstract][Full Text] [Related]
56. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1.
Mautner VF; Hartmann M; Kluwe L; Friedrich RE; Fünsterer C
Neuroradiology; 2006 Mar; 48(3):160-5. PubMed ID: 16432718
[TBL] [Abstract][Full Text] [Related]
57. Selumetinib: the first ever approved drug for neurofibromatosis-1 related inoperable plexiform neurofibroma.
Mukhopadhyay S; Maitra A; Choudhury S
Curr Med Res Opin; 2021 May; 37(5):789-794. PubMed ID: 33683166
[TBL] [Abstract][Full Text] [Related]
58. Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.
Grit JL; Johnson BK; Dischinger PS; J Essenburg C; Adams M; Campbell S; Pollard K; Pratilas CA; Triche TJ; Graveel CR; Steensma MR
Epigenetics Chromatin; 2021 Jan; 14(1):7. PubMed ID: 33436083
[TBL] [Abstract][Full Text] [Related]
59. Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene.
Veres K; Bene J; Hadzsiev K; Garami M; Pálla S; Happle R; Medvecz M; Szalai ZZ
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569527
[TBL] [Abstract][Full Text] [Related]
60. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
